Journals / Turkish Journal of Hematology / 2013 / Cilt: 30 - Sayı: 2

Hidroksiüre’nin anlatılmamış hikayesi: Bacak ülserli 3 olgunun tedavisi

Successful management of Hydroxyurea-induced Leg ulcers in essential thrombocythemia: Report of 3 cases

Pages
184–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Awareness of this important treatment complication is important to avoid the pitfall of futile invasive interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Essential thrombocythemia is one of the myeloproliferative neoplasms with a plethora of thrombohemorrhagic complications.
📊
Key Findings & Data:We herein report 3 patients with essential thrombocythemia treated with hydroxyurea who developed refractory leg ulcers, and we outline their successful management.
💡
Conclusion & Impact:Awareness of this important treatment complication is important to avoid the pitfall of futile invasive interventions.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Essential thrombocythemia is one of the myeloproliferative neoplasms with a plethora of thrombohemorrhagic complications. Hydroxyurea has been proven to be an effective treatment for this condition. However, it is not without side effects. We herein report 3 patients with essential thrombocythemia treated with hydroxyurea who developed refractory leg ulcers, and we outline their successful management. We also review the literature to shed light on the mechanism of this toxicity. Awareness of this important treatment complication is important to avoid the pitfall of futile invasive interventions.

Özet

Esansiyel trombositoz, trombohemorajik komplikasyonların sık görüldüğü miyeloproliferatif hastalıklardan biridir. Hidroksiürenin bu durum için etkili bir tedavi olduğu kanıtlanmıştır. Bununla birlikte, yan etkisiz değildir. Bu makalede refrakter bacak ülserleri gelişen 3 esansiyel trombositoz hastasında hidroksiüre ile başarılı şekilde gerçekleştirilen tedavi sürecini bildiriyoruz. Aynı zamanda, bu toksisitenin mekanizmasına ışık tutacak literatür gözden geçirilmiştir. Bu önemli komplikasyonun farkında olmak, gereksiz invaziv girişimlerden kaçınmak için önemlidir.

🔖

Cite This Article

RAHAL, J. A., ISHAK, S. R., OTROCK, K. Z., MAAKARON, E. J., GHOSN, S., TAHER, T. A. (2013). Hidroksiüre’nin anlatılmamış hikayesi: Bacak ülserli 3 olgunun tedavisi. Turkish Journal of Hematology, Cilt: 30 - Sayı: 2, 184–187. https://ajindex.com/articles/412856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tefferi A. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012;87:285–293
  2. Demircay Z, Comert A, Adiguzel C. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia. Int J Dermatol 2002;41:872–874
  3. Tsuchiya S, Ichioka S, Sekiya N. Hydroxyurea-induced foot ulcer in a case of essential thrombocythaemia. J Wound Care 2010;19:361–364
  4. Kikuchi K, Arita K, Tateishi Y, Onozawa M, Akiyama M, Shimizu H. Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment. Acta Derm Venereol 2011;91:373–374
  5. Radaelli F Calori R, Faccini P, Maiolo AT. Early cutaneous lesions secondary to hydroxyurea therapy. Am J Hematol 1998;58:82–83
  6. Richard M, Truchetet F Friedel J, Leclech C, Heid E. Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy. J Am Acad Dermatol 1989;21:797–799
  7. Renfro L, Kamino H, Raphael B, Moy J, Sanchez M. Ulcerative lichen planus-like dermatitis associated with hydroxyurea. J Am Acad Dermatol 1991;24:143–145
  8. Papi M, Didona B, DePità O, Abruzzese E, Stasi R, Papa G, Cavalieri R. Multiple skin tumors on light-exposed areas during long-term treatment with hydroxyurea. J Am Acad Dermatol 1993;28:485–486
  9. Najean Y, Rain JD. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997;90:3370–3377
  10. Martorell-Calatayud A, Requena C, Nagore-Enguídanos E, Guillén-Barona C. [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea]. Actas Dermosifiliogr 2009;100:804–807
  11. Ruzzon E, Randi ML, Tezza F Luzzatto G, Scandellari R, Fabris F Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature. Aging Clin Exp Res 2006;18:187–190
  12. Middelhoff G, Boll I. A long-term clinical trial of interferon alpha-therapy in essential thrombocythemia. Ann Hematol 1992;64:207–209.